Register now to our Newsletter

TransCure bioServices hires 3 new employees.

BMS and Viiv published in vivo efficacy data on a new anti-HIV treatment using our Advanced Human Immune System Mouse Models.

Find more about how TransCure improves Inflammatory Bowel Diseases research with its humanized mouse model.

A friendly day on Lake Leman for the TransCure bioServices team!

The NEWTON bioluminescence imaging system allows for the non-invasive detection and quantification from the onset throughout full development of any tumor.

Demonstration of viral clearance targeting latent infectious reservoirs in HIV-1 infected CD34+ human immune system mice treated with LASER ART and CRISPR-Cas9 is available.

Patrick NEF gives a global presentation about TransCure bioServices SAS during an interview for the TV channel 8 Mont-Blanc

TransCure bioServices hires Hélène DELPECH - New Research Engineer

What services TransCure bioServices is offering? Who are its clients? What are its achievements? What are its news goals and new challenges with its recent funding of 2.5 million euros? Get the answers in the ECO article. (article n french).

New financing round will enable the company to accelerate its growth and expand its international services offers.